{
    "SPADE_N_13829": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_N_13829",
            "Peptide Name": "P1 (Val-rich; natural AMPs; bacteriocin, bacteria, prokaryotes; UCLL1a; BBMm)",
            "Source": "a soil bacterium,Brevibacillussp. SPR-20",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "VVVNVLVKVLPPPVV",
            "Sequence Length": 15,
            "UniProt Entry": "Ref",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-MRSA"
            ],
            "Target Organism": "Not found",
            "Hemolytic Activity": "Not found",
            "Cytotoxicity": "Not found",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Not found",
            "N-terminal Modification": "Not found",
            "C-terminal Modification": "Not found",
            "Stereochemistry": "Not found",
            "Structure Description": "Not found",
            "Formula": "Not found",
            "Mass": 1571.0,
            "PI": 8.72,
            "Hydrophobicity": 1.93,
            "Half Life": "Not found",
            "Function": "Not found",
            "Literature": [
                {
                    "Author": "Songnaka N, Lertcanawanichakul M, Hutapea AM, Krobthong S, Yingchutrakul Y, Atipairin A. 2022",
                    "Reference": "Molecules. 2022; 27(23):8452. https://doi.org/10.3390/molecules27238452.MDPI",
                    "Title": "Purification and Characterization of Novel Anti-MRSA Peptides Produced by Brevibacillus sp. SPR-20."
                }
            ],
            "Frequent Amino Acids": "VPL",
            "Absent Amino Acids": "ACDEFGHIMOQRSTUWY",
            "Basic Residues": 1,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 13,
            "Polar Residues": 10,
            "Positive Residues": 1,
            "Negative Residues": 0,
            "Net Charge": 1,
            "Comments": "Sequence analysis: APD analysis reveals this sequence is most similar (50%) toAcidocin LCHVV: 53%, P: 20%; L: 13%. GRAVY: 1.93; M Wt: 1571.024; Mol formula: C77H136N16O17; Mol ex coeff: 0.Activity: active against S. aureus TISTR 517 (MIC 2 ug/ml), MRSA isolate 142 (MIC 2 ug/ml), MRSA isolate 1096 (MIC 2 ug/ml), MRSA isolate 2468 (MIC 2 ug/ml).Antimicrobial robustness: Peptide P1 retained activty at pH 2 to 14, after autocalve, or in the presence of proteinase K, trypsin, or chynotrypsin.MOA: Peptide P1 can permeate bacterial membranes.Structure: helical in membrane-mimetic SDS micelles.Toxicity: human RBC: Peptide P1 is not hemo-lytic tll 32 ug/ml. It, however, caused more than 50% hemolysis at 64 ug/ml. Hence, the peptide is not toxic at its MIC (2 ug/ml).",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_04605",
                    "Similarity": 1.0,
                    "Sequence": "VVVV"
                },
                {
                    "SPADE_ID": "SPADE_N_06854",
                    "Similarity": 0.8,
                    "Sequence": "VVVVTV"
                },
                {
                    "SPADE_ID": "SPADE_N_01077",
                    "Similarity": 0.8,
                    "Sequence": "GVIDAAKKVVNVLKNLP"
                }
            ]
        }
    }
}